Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements (Details) - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Liabilities
Warrant liabilities	$ 916	$ 1,648
Contingent success fee liability	40
Fair Value, Measurements, Recurring [Member]
Liabilities
Warrant liabilities	916	1,648
Contingent consideration liability	33	42
Contingent success fee liability	40	39
Quoted Prices in Active Markets for Identical Items Level 1 [Member] \| Fair Value, Measurements, Recurring [Member]
Liabilities
Warrant liabilities	0	0
Contingent consideration liability	0	0
Contingent success fee liability	0	0
Significant Other Observable Inputs Level 2 [Member] \| Fair Value, Measurements, Recurring [Member]
Liabilities
Warrant liabilities	0	0
Contingent consideration liability	0	0
Contingent success fee liability	0	0
Significant Unobservable Inputs Level 3 [Member] \| Fair Value, Measurements, Recurring [Member]
Liabilities
Warrant liabilities	916	1,648
Contingent consideration liability	33	42
Contingent success fee liability	$ 40	$ 39